Bumper Offer - Urjas oil Just @ Rs. 1
Met XL AM 50/5 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. The alternative uses of Met XL AM 50/5 Tablet (15) have also been explained below.
The right dosage of Met XL AM 50/5 Tablet (15) depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Met XL AM 50/5 Tablet (15) include Slow heart rate (pulse). Some other side effects of Met XL AM 50/5 Tablet (15) have been listed ahead. Such side effects of Met XL AM 50/5 Tablet (15) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
In addition, Met XL AM 50/5 Tablet (15)'s effect is Severe during pregnancy and Mild for lactating mothers. Warnings related to Met XL AM 50/5 Tablet (15)'s effects on the liver, heart and kidney, if any, have been listed below.
Met XL AM 50/5 Tablet (15) is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease as it can result in adverse effects. Some other conditions that can be affected by Met XL AM 50/5 Tablet (15) are listed in the contraindications section below.
Besides this, Met XL AM 50/5 Tablet (15) may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Met XL AM 50/5 Tablet (15) is not safe while driving, and is is not addictive in nature.
Met XL AM 50/5 Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Met XL AM 50/5 Tablet (15) is used -
Moderate
Mild
Common
Is the use of Met XL AM 50/5 Tablet (15) safe for pregnant women?
Pregnant women may get severe side effects after taking Met XL AM. If you are pregnant, do not take Met XL AM without a doctor's advice.
Is the use of Met XL AM 50/5 Tablet (15) safe during breastfeeding?
Side effects of Met XL AM for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Met XL AM 50/5 Tablet (15) on the Kidneys?
Using Met XL AM does not have any harmful effects on kidneys.
What is the effect of Met XL AM 50/5 Tablet (15) on the Liver?
Met XL AM is rarely harmful for the liver.
What is the effect of Met XL AM 50/5 Tablet (15) on the Heart?
Side effects of Met XL AM rarely affect the heart.
Met XL AM 50/5 Tablet (15) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Met XL AM 50/5 Tablet (15) unless your doctor advises you to do so -
Is this Met XL AM 50/5 Tablet (15) habit forming or addictive?
Met XL AM 50/5 Tablet (15) is not addictive in nature.
Interaction between Food and Met XL AM 50/5 Tablet (15)
Eating certain foods may increase the time it takes Met XL AM 50/5 Tablet (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Met XL AM 50/5 Tablet (15)
Taking Met XL AM 50/5 Tablet (15) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
